Complex visual discrimination of tradimensional patterns in rats

The neurodegenerative disorders (NDDs) are characterized by protein and other pathologies which can be reflected in biofluids. • The use of cerebrospinal fluid (CSF) analysis and molecular imaging has been critical in stratifying populations based on diagnosis and underlying pathology, but are limited as population screening tools. • Advances in ultra-sensitive immunoassay measurement of amyloid-β, neurofilament light and tau, as well as mass spectrometry-based methods for amyloid, have demonstrated that a blood-based screening tool for Alzheimer's disease (AD) is a realistic and plausible possibility. • This evidence is now indicating that such blood biomarkers could be important for other common NDDs (e.g, LBD & FTD).

show abstract

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

Ashton

et al. 2020

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Complex visual discrimination of tradimensional patterns in rats

Cited by 1 publication

References 23 publications

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

Contact Info

Product

Resources

About